AstraZeneca recalls physician sample bottles of heart drug

AstraZeneca is voluntarily recalling one lot of physician sample bottles of Brilinta — a blood-thinning drug prescribed to prevent stroke, heart attack and other heart problems — as a precautionary measure. The London-based pharmaceutical company, which has its U.S. headquarters in Wilmington, said the voluntary recall follows a report that a professional sample bottle containi ng eight, 90 milligram tablets of Brilinta also contained another medicine, Zurampic tablets, also manufactured by AstraZeneca…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news